1102 related articles for article (PubMed ID: 31111345)
21. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
Chang TT; Liaw YF; Wu SS; Schiff E; Han KH; Lai CL; Safadi R; Lee SS; Halota W; Goodman Z; Chi YC; Zhang H; Hindes R; Iloeje U; Beebe S; Kreter B
Hepatology; 2010 Sep; 52(3):886-93. PubMed ID: 20683932
[TBL] [Abstract][Full Text] [Related]
22. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
Lemoine M; Shimakawa Y; Nayagam S; Khalil M; Suso P; Lloyd J; Goldin R; Njai HF; Ndow G; Taal M; Cooke G; D'Alessandro U; Vray M; Mbaye PS; Njie R; Mallet V; Thursz M
Gut; 2016 Aug; 65(8):1369-76. PubMed ID: 26109530
[TBL] [Abstract][Full Text] [Related]
23. The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B.
Zhong LK; Zhang G; Luo SY; Yin W; Song HY
J Clin Lab Anal; 2020 Jul; 34(7):e23270. PubMed ID: 32363594
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
[TBL] [Abstract][Full Text] [Related]
25. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS).
Teshale E; Lu M; Rupp LB; Holmberg SD; Moorman AC; Spradling P; Vijayadeva V; Boscarino JA; Schmidt MA; Gordon SC;
J Viral Hepat; 2014 Dec; 21(12):917-20. PubMed ID: 25131445
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
[TBL] [Abstract][Full Text] [Related]
27. Serum HBV RNA levels predict significant liver fibrosis in patients with chronic HBV infection.
Huang C; Li Q; Xu W; Wang Q; Hu Q; Zhang X; Huang Y; Chen L
Discov Med; 2020; 29(157):119-128. PubMed ID: 33002408
[TBL] [Abstract][Full Text] [Related]
28. The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China.
Huang D; Lin T; Wang S; Cheng L; Xie L; Lu Y; Chen M; Zhu L; Shi J
BMC Infect Dis; 2019 Oct; 19(1):878. PubMed ID: 31640590
[TBL] [Abstract][Full Text] [Related]
29. Cirrhosis has no impact on therapeutic responses of entecavir for chronic hepatitis B.
Wang PC; Wei TY; Tseng TC; Lin HH; Wang CC
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):946-950. PubMed ID: 28538267
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B core-related antigen serum levels are associated with significant liver fibrosis in treatment-naive chronic HBV infection patients.
Liu R; Li M; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hao H; Hu L; Gao Y; Xu M; Xie Y
J Viral Hepat; 2022 Jun; 29(6):438-446. PubMed ID: 35357759
[TBL] [Abstract][Full Text] [Related]
31. Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis B.
Alswat K; Soliman R; Mikhail NNH; Örmeci N; Dalekos GN; Derbala MFM; Al-Busafi SA; Hamoudi W; Shiha G
Saudi J Gastroenterol; 2024 May; 30(3):138-144. PubMed ID: 38482630
[TBL] [Abstract][Full Text] [Related]
32. A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir.
Chiang HH; Lee CM; Hu TH; Hung CH; Wang JH; Lu SN; Lai HC; Su WP; Lin CH; Peng CY; Chen CH
Liver Int; 2018 Nov; 38(11):1997-2005. PubMed ID: 29797410
[TBL] [Abstract][Full Text] [Related]
33. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
34. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Li Q; Lu C; Li W; Huang Y; Chen L
Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.
Wang J; Sun X; Wei S; Chen X; Zhu H; Liantang Y; Bao R; Du Y
BMC Gastroenterol; 2024 May; 24(1):183. PubMed ID: 38783185
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
Ma J; Jiang Y; Gong G
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):428-34. PubMed ID: 23358121
[TBL] [Abstract][Full Text] [Related]
37. Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy.
Song BG; Sinn DH; Chi S; Kim K; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1447-1452. PubMed ID: 30063482
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Liver Fibrosis Using Real-time Shear-wave Elastography for Patients with Hepatitis B e Antigen-negative Chronic Hepatitis B and Alanine Transaminase <2 Times the Upper Limit of Normal.
Liu JH; Zou Y; Chang W; Wu J; Zou Y; Xie YC; Lu YP; Wei J
Rev Invest Clin; 2017; 69(5):254-261. PubMed ID: 29077697
[TBL] [Abstract][Full Text] [Related]
39. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.
Ragazzo TG; Paranagua-Vezozzo D; Lima FR; de Campos Mazo DF; Pessoa MG; Oliveira CP; Alves VAF; Carrilho FJ
Clinics (Sao Paulo); 2017 Oct; 72(9):516-525. PubMed ID: 29069254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
